OSE Immunotherapeutics SA Profile Avatar - Palmy Investing

OSE Immunotherapeutics SA

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of no…

Biotechnology
FR, Nantes [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of OSE Immunotherapeutics SA

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of OSE.PA's Analysis
CIK: - CUSIP: F6913C100 ISIN: FR0012127173 LEI: - UEI: -
Secondary Listings
OSE.PA has no secondary listings inside our databases.